Cure8 news brief
Patients with IBD have an increased colorectal cancer risk, and those with PSC, extensive colitis, severe inflammation, or prior dysplasia are at especially high risk. High-quality surveillance techniques can improve dysplasia detection and influence management decisions (endoscopic resection vs surgery).
Clinicians doing IBD surveillance (gastroenterologists, endoscopists), colorectal surgeons, and patients with IBD—particularly those with PSC, extensive colitis, severe inflammation, or prior dysplasia.
This conference video and clinical practice summary from Dr. Nayantara Coelho-Prabhu summarizes current recommendations for colorectal cancer surveillance in IBD, with special emphasis on patients with primary sclerosing cholangitis (PSC) who are at higher risk.
Key practical points covered include optimizing bowel prep and performing surveillance during endoscopic remission, using high-definition colonoscopy and either dye or virtual chromoendoscopy (or segmental reinspection with high-definition white light), obtaining four-quadrant random biopsies for PSC or prior dysplasia, and considering advanced endoscopic resection (EMR/ESD) for visible dysplasia.
If a visible lesion cannot be safely resected endoscopically (e.g., adenocarcinoma on biopsy, marked submucosal fibrosis, or uncontrolled active inflammation), referral to colorectal surgery is advised.
The talk also highlights documentation standards for lesions (morphology, site, size, surface pattern, surrounding mucosa) and surveillance intervals (3–12 months after dysplasia resection; 1, 3, or 5 years without dysplasia).
Conference summary and expert guidance from ACG coverage; not a formal guideline or new clinical-trial report. Recommendations align with current practices emphasizing high-definition imaging, chromoendoscopy or careful reinspection, and targeted/random biopsies for high-risk patients.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with IBD have a higher lifetime risk of colorectal cancer; updated UK guidelines give clinicians and patients evidence-based recommendations on when and how to do surveillance colonoscopy to detect precancerous...
This study evaluated whether blood levels of LRG track endoscopic and clinical disease activity in people with suspected UC or Crohn’s disease, which could point to a noninvasive inflammation biomarker.
Depression before an IBD diagnosis was linked to more early treatment escalation and acute-care use after diagnosis. Recognizing preexisting depression could help clinicians identify patients who may benefit from closer...
